The indicating FTA elute cartridge: A solid sample carrier to detect high-risk HPV and high-grade cervical lesions

Journal of Molecular Diagnostics

Volumn 13, Issue 4, 2011, Pages 371-376

  De Bie, Roosmarie P ^a   Schmeink, Channa E ^a   Bakkers, Judith M J E ^a   Snijders, Peter J F ^b   Quint, Wim G V ^c   Massuger, Leon F A G ^a   Bekkers, Ruud L M ^a   Melchers, Willem J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DDL Diagnostic Laboratory   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CANCER GRADING; ELUTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VALIDATION PROCESS; VIRUS DETECTION; WART VIRUS; AGED; ALPHAPAPILLOMAVIRUS; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; GENETICS; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; UTERINE CERVICAL NEOPLASMS; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

EID: 80054065623     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2011.02.003     Document Type: Article

References (22)

1. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007, 370:1764-1772 (Pubitemid 350137476)
2. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J: Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010, 11:249-257
3. Brink AA, Meijer CJ, Wiegerinck MA, Nieboer TE, Kruitwagen RF, van Kemenade F, Fransen DN, Hesselink AT, Berkhof J, Snijders PJ: High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol 2006, 44:2518-2523 (Pubitemid 44092421)
4. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, Arias C, Manetta A: Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008, 17:2163-2168
5. Harper DM, Noll WW, Belloni DR, Cole BF: Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol 2002, 186:365-373 (Pubitemid 34234143)
6. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ: Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002, 55:435-439 (Pubitemid 34620780)
7. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M: Comparison of self-collected vaginal, vulvar and urine samples with physician- collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000, 163:513-518
8. Winer RL, Feng Q, Hughes JP, Yu M, Kiviat NB, O'Reilly S, Koutsky LA: Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age. Sex Transm Dis 2007, 34:371-377 (Pubitemid 46816783)
9. Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM: Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005, 81:207-212 (Pubitemid 40835044)
10. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F: Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? a systematic review and meta-analysis. Gynecol Oncol 2007, 105:530-535 (Pubitemid 46590347)
11. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ: Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007, 120:1505-1510 (Pubitemid 46355385)
12. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Belien JA, Babovic M, Snijders PJ, Meijer CJ: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010, 340:c1040
13. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, Wardle J: Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006, 13:208-213 (Pubitemid 46057729)
14. Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, Groningen K, Boon ME, Keuning HJ, van Ballegooijen M, van den Brule AJ, Meijer CJ: POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004, 110:94-101 (Pubitemid 38507208)
15. Sanner K, Wikstrom I, Strand A, Lindell M, Wilander E: Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009, 101:871-874
16. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A: HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000, 283:81-86 (Pubitemid 30038387)
17. Lenselink CH, de Bie RP, van Hamont D, Bakkers JM, Quint WG, Massuger LF, Bekkers RL, Melchers WJ: Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol 2009, 47:2564-2570
18. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ: Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009, 124:516-520
19. Hesselink AT, van Ham MA, Heideman DA, Groothuismink ZM, Rozendaal L, Berkhof J, van Kemenade FJ, Massuger LF, Melchers WJ, Meijer CJ, Snijders PJ: Comparison of GP5+/6+-PCR and SPF10-Line Blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia. J Clin Microbiol 2008, 46:3215-3221
20. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002, 40:779-787 (Pubitemid 34208623)
21. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM: A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997, 35:791-795 (Pubitemid 27083888)
22. Gustavsson I, Lindell M, Wilander E, Strand A, Gyllensten U: Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol 2009, 46:112-116